Uniphar (LON:UPR) Stock Price Down 0.5% – Here’s Why

Shares of Uniphar plc (LON:UPRGet Free Report) were down 0.5% during trading on Tuesday . The stock traded as low as GBX 196 ($2.47) and last traded at GBX 199.05 ($2.51). Approximately 6,653 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 32,461 shares. The stock had previously closed at GBX 200 ($2.52).

Wall Street Analysts Forecast Growth

Separately, Shore Capital reiterated a “buy” rating on shares of Uniphar in a research note on Tuesday, January 28th.

Get Our Latest Stock Report on UPR

Uniphar Stock Down 0.5 %

The company has a market cap of £613.23 million, a P/E ratio of 13.70 and a beta of 0.75. The company has a debt-to-equity ratio of 119.48, a current ratio of 0.90 and a quick ratio of 0.60. The business’s 50 day moving average price is GBX 181.41 and its 200-day moving average price is GBX 197.94.

About Uniphar

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

Recommended Stories

Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.